Growth Metrics

Beta Bionics (BBNX) Other Non Operating Income (2024 - 2025)

Beta Bionics recorded quarterly Other Non Operating Income of $1000.0 in Q3 2025, up 150.0% quarter-over-quarter from -$2000.0 in Q2 2025, and up 125.0% year-over-year from $444.44 in Q3 2024.

Beta Bionics' Other Non Operating Income history runs 2 years deep, the most recent figure standing at $1000.0 for Q3 2025.

  • In Q3 2025, Other Non Operating Income rose 125.0% year-over-year to $1000.0; the TTM figure through Dec 2025 stood at -$1000.0 (up 50.0% YoY), while the FY2025 annual figure was -$1000.0, up 50.0% from the prior year.
  • Other Non Operating Income came in at $1000.0 for Q3 2025 at Beta Bionics, up from -$2000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $4000.0 in Q1 2024 to a low of -$4000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Beta Bionics 572.34 Mn 542.03 Mn 16.44 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 1,000.00
Jun 30, 2025 -2,000.00
Sep 30, 2024 -4,000.00
Jun 30, 2024 -2,000.00
Mar 31, 2024 4,000.00